Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society
|
January 13, 2016
Lipoprotein(a): Revisiting a Next Therapeutic Target
Kouji Kajinami
Circulation Journal : Official Journal of the Japanese Circulation Society
|
March 13, 2018
Towards Effective Cost-Effectiveness Analysis in Atherosclerotic Cardiovascular Disease Prevention
Kouji Kajinami
Expert Opinion on Investigational Drugs
|
May 31, 2002
Cholesterol absorption inhibitors in development as potential therapeutics
Kouji Kajinami, Noboru Takekoshi
Atherosclerosis
|
December 22, 2011
Probucol: can we step forward in atherosclerosis prevention with an old drug?
Kouji Kajinami, Hironobu Akao
Clinical Medicine Insights. Case Reports
|
November 28, 2022
A Case of Myopericarditis After the Second Dose of mRNA COVID-19 Vaccine in a Patient With a History of Myopericarditis
Kosuke Fujibayashi, Kouji Kajinami
Atherosclerosis
|
November 2, 2010
Beyond C-reactive protein; new evidence for another inflammatory biomarker predicting cardiovascular disease risk
Kouji Kajinami, Yasuyuki Kawai
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 8, 2007
[Gene mutations responsible for hyperlipoproteinemia]
Ryoko Sato, Mizuho Okabayashi, Kouji Kajinami
Biological & Pharmaceutical Bulletin
|
August 31, 2025
Trastuzumab Cardiotoxicity: Mechanism and Management
Minoru Wakasa, Miharu Masaki, Kouji Kajinami
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
January 19, 2006
[Genetic testing and gene-based testing for hyperlipidemia and lipid metabolism disorders]
Kouji Kajinami, Mizuho Okabayashi, Ryoko Sato
Clinical Case Reports
|
April 18, 2024
Marchiafava-Bignami disease: Prompt diagnosis made by magnetic resonance brain imaging
Satori Akita, Takeshi Takakuwa, Kouji Kajinami
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Circulation Journal : Official Journal of the Japanese Circulation Society
|
January 13, 2016
Lipoprotein(a): Revisiting a Next Therapeutic Target
Kouji Kajinami
Circulation Journal : Official Journal of the Japanese Circulation Society
|
March 13, 2018
Towards Effective Cost-Effectiveness Analysis in Atherosclerotic Cardiovascular Disease Prevention
Kouji Kajinami
Expert Opinion on Investigational Drugs
|
May 31, 2002
Cholesterol absorption inhibitors in development as potential therapeutics
Kouji Kajinami, Noboru Takekoshi
Atherosclerosis
|
December 22, 2011
Probucol: can we step forward in atherosclerosis prevention with an old drug?
Kouji Kajinami, Hironobu Akao
Clinical Medicine Insights. Case Reports
|
November 28, 2022
A Case of Myopericarditis After the Second Dose of mRNA COVID-19 Vaccine in a Patient With a History of Myopericarditis
Kosuke Fujibayashi, Kouji Kajinami
Atherosclerosis
|
November 2, 2010
Beyond C-reactive protein; new evidence for another inflammatory biomarker predicting cardiovascular disease risk
Kouji Kajinami, Yasuyuki Kawai
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 8, 2007
[Gene mutations responsible for hyperlipoproteinemia]
Ryoko Sato, Mizuho Okabayashi, Kouji Kajinami
Biological & Pharmaceutical Bulletin
|
August 31, 2025
Trastuzumab Cardiotoxicity: Mechanism and Management
Minoru Wakasa, Miharu Masaki, Kouji Kajinami
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
January 19, 2006
[Genetic testing and gene-based testing for hyperlipidemia and lipid metabolism disorders]
Kouji Kajinami, Mizuho Okabayashi, Ryoko Sato
Clinical Case Reports
|
April 18, 2024
Marchiafava-Bignami disease: Prompt diagnosis made by magnetic resonance brain imaging
Satori Akita, Takeshi Takakuwa, Kouji Kajinami
Page
of 8